ROPER TECHNOLOGIES INC quarterly report, Q3 FY2014

Roper Industries, Inc. — Form 10-Q Summary

Period: Third quarter and nine months ended September 30, 2014. The filing identifies the registrant as Roper Industries, Inc. (the request metadata names Roper Technologies Inc.). Amounts are in U.S. dollars; financial statement amounts are generally in millions unless noted.

Business context and results

Roper is a diversified technology company with four segments: Industrial Technology, Energy Systems & Controls, Medical & Scientific Imaging, and RF Technology. It emphasizes organic operating improvements and acquisitions.

MetricQ3 2014Q3 2013Nine months 2014Nine months 2013
Revenue$884.1$827.8$2,603.3$2,349.0
Operating income$245.7$219.3$715.7$584.3
Net earnings$155.5$136.3$460.1$372.6
Diluted EPS$1.54$1.36$4.56$3.72
Gross margin59.3%58.3%59.0%57.5%
Net margin17.6%16.5%17.7%15.9%
Operating cash flow$226.1$255.8$579.2$566.8

Q3 revenue grew 6.8% year over year, including 5% organic growth and 2% from acquisitions; nine-month revenue rose 10.8%, including 7% organic growth and 4% from acquisitions. Segment revenue was strongest in Medical & Scientific Imaging, up 13% in Q3 and 23% year to date. Its operating margin improved to 33.9% for Q3 and 34.7% for the nine months. Q3 segment order intake was $893.4 million, up 7%; backlog at quarter-end was $1.073 billion, up 3% year over year.

Financial position, liquidity and debt

  • At September 30, cash and equivalents were $564.1 million, versus $459.7 million at December 31, 2013. Current assets were $1.533 billion and current liabilities $662.0 million.
  • Total debt was $2.370 billion, down from $2.465 billion at year-end; net debt fell to $1.805 billion from $2.005 billion. Net debt to total net capital improved to 28.0% from 32.2%.
  • Debt included $2.2 billion of fixed-rate senior notes, $155 million drawn on the $1.5 billion revolving facility, and approximately $7.9 million of convertible notes. The company reported compliance with debt covenants.
  • Operating cash flow was $579.2 million for the first nine months. Investing used $340.4 million, principally for acquisitions; financing used $113.5 million, including net debt repayments and dividends. Capital expenditures were $29.8 million.
  • Cash held at foreign subsidiaries was $495 million and was considered permanently reinvested; repatriation for U.S. use could incur additional taxes. Management said available cash, U.S. operating cash flows, credit facilities and capital-market access should fund U.S. operating needs for the foreseeable future.

Changes, outlook and risks

  • Profitability improved year over year, with gross margin rising 1.0 percentage point in Q3 and 1.5 points for the nine-month period. Interest expense declined to $20.0 million in Q3 and $59.4 million year to date, attributed to lower average rates and debt balances.
  • Q3 operating cash flow was lower than a year earlier, primarily due to higher tax payments and weaker receivables collections. Nine-month operating cash flow increased modestly, with earnings growth offset partly by tax payments and receivables.
  • Foreign-exchange translation reduced comprehensive income by $60.8 million in Q3 and $53.8 million for the nine months, net of tax. Management said much of the related goodwill impact did not directly affect expected future cash flows.
  • Management expected an approximately 31% effective tax rate for 2014, capital expenditures for the rest of the year comparable to prior years as a percentage of sales, and positive acquired-company cash flows to support debt reduction. No specific earnings or revenue guidance was provided.
  • The company made acquisitions during the quarter; Foodlink, SHP and IPA are identified in the filing text. The supplied text does not preserve clear acquisition consideration, goodwill/intangible allocation, or transaction-cost amounts. Purchase price allocations were preliminary.
  • Risks include acquisition integration and financing, indebtedness and interest rates, foreign exchange, cyclical markets, large-customer and government-contract exposure, product liability and warranties, and substantial goodwill and intangible assets. Roper noted Puerto Rico legislation that may affect its customer, the Puerto Rico Highways & Transportation Authority, while stating it expected existing contracts and payables to be honored. It also described asbestos-related claims, for which potential liability could not be determined; management did not expect pending legal matters to materially affect the company.

Important facts for investors to verify

  • Confirm acquisition identities, consideration, preliminary purchase accounting and any integration or financing effects; relevant dollar amounts are unclear in the supplied filing text.
  • Assess sustainability of organic growth, especially the contribution of Medical & Scientific Imaging and the Q3 order/backlog trends.
  • Monitor conversion of earnings to operating cash flow, working-capital movements, and progress on debt reduction.
  • Evaluate access to the $495 million of foreign-held cash, potential repatriation taxes, and exposure to exchange-rate movements.
  • Track customer and government-contract concentration, including developments affecting the Puerto Rico transportation authority, as well as litigation and warranty exposure.